Navigation Links
Neura Therapeutik Forms Business Units to Pursue Analgesic Market Opportunities
Date:7/31/2012

PRINCETON, N.J., July 31, 2012 /PRNewswire/ -- Neura Therapeutik, LLC, a privately held specialty pharmaceutical company, announced today the formation of two strategic business units to capitalize on current and future opportunities in the analgesic market. The formation of Neura Group, LLC and Neura Labs, LLC structures the company to efficiently pursue commercial services, in-licensing, and joint venture opportunities in the analgesic marketplace.

Established by former King and Pfizer executives in 2010, Neura Therapeutik brings expertise in commercialization and development of analgesics, primarily in the NSAID and opioid classes of the pain market. Management's past experience includes directing pain franchise build outs and launching some of the largest US analgesic brands including Duragesic® patch and Vicodin ES® tablets. The formation of the business units allows Neura the ability to fully leverage its expertise in the analgesic market and build strong working alliances with strategic operational partners.

Through in-licensing and joint venture arrangements, the Neura Labs business unit will focus on establishing a portfolio of analgesic products with unique characteristics that fulfill unmet market needs, reside in the opioid and more specifically the tamper-resistant segment, or that have a high therapeutic index, or other unique pharmacokinetic or functional characteristics.

The Neura Group business unit provides companies interested in entering the analgesic market with a highly experienced turn-key commercial infrastructure and leadership team capable of rapidly establishing a total US operational presence. Neura Group offers best-in-class functional area expertise in CMC, regulatory and manufacturing scale-up to sales, marketing, launch readiness and lifecycle management.

"There are many nuances associated with analgesic commercialization. A commercial team with experience navigating the US analgesic marketplace is critical for the success of any product seeking to enter this market," said John La Lota, CEO of Neura Therapeutik. "Neura Therapeutik's two strategic business units provide an efficient solution to companies requiring an analgesic experienced commercial team whether they wish to retain the asset and leverage our commercial expertise, or if they seek an experienced company as a licensing partner."

Duragesic® is a registered trademark of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Vicodin ES® is a registered trademark of Abbott Laboratories.

Contact:

Neura Therapeutik, LLC
Greg Gironda: girondag@neuratherapeutik.com 
Visit: www.neuratherapeutik.com

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com


'/>"/>
SOURCE Neura Therapeutik, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Seventeenth Patient Dosed in Neuralstem ALS Stem Cell Trial
2. First Patients Dosed in Ib Phase of Neuralstems NSI-189 Trial in Major Depressive Disorder
3. Sixteenth Patient Dosed In Neuralstem ALS Stem Cell Trial
4. Neuralstem Updates ALS Stem Cell Trial Progress
5. Sanovas Forms Scientific Advisory Board to Support Development of Lung Cancer Technology
6. BioSurplus Forms New Division for Auction Services
7. Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media
8. ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report
9. inVentiv Medical Management Forms Partnership with Vital Decisions
10. Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production
11. Simbionix Releases Two New Platforms at the Upcoming DDW and AUA Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
(Date:6/24/2016)... June 24, 2016  Collagen Matrix, Inc., ("Collagen ... and manufacturing of collagen and mineral based medical ... that Bill Messer has joined the ... further leverage the growing portfolio of oral surgery, ... Bill joins the Collagen Matrix executive team ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
Breaking Medicine Technology:
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
Breaking Medicine News(10 mins):